Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phakomatoses.

Benjamin Becker1, Roy E Strowd2

  • 1Department of Neurology, Wake Forest Baptist Health, 1 Medical Center Boulevard, Winston Salem, NC 27157, USA.

Dermatologic Clinics
|August 31, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic pain and stress: Transdiagnostic meta-analytic evidence of convergent network signature with PTSD.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Modulation of emotion regulation deficits in patients with heroin use disorder by intermittent Theta-burst transcranial magnetic stimulation.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Top-down rather than bottom-up attention processing mediates the pathway from childhood trauma exposure to depression in adolescents.

Journal of psychiatric research·2026
Same author

Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.

Journal of neuro-oncology·2026
Same author

How Standardized Is Transcranial Magnetic Stimulation Treatment for Depression? Large-Cohort Modeling Reveals Systematic Dosimetric Variability.

Psychotherapy and psychosomatics·2026
Same author

Disgust Propensity, Not Disgust Sensitivity, Shapes the Reactivity of a Subjective Disgust Circuit in Humans.

Human brain mapping·2026
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Phakomatoses, like Neurofibromatosis type 1 and Tuberous Sclerosis Complex, involve skin, nervous system, and tumor manifestations. Management requires supportive care, tumor surveillance, and comorbid condition treatment.

Area of Science:

  • Genetics and Neurology
  • Dermatology
  • Oncology

Background:

  • Phakomatoses are a group of neurocutaneous disorders.
  • Neurofibromatosis type 1 (NF1) and Tuberous Sclerosis Complex (TSC) are common examples.
  • These conditions manifest with distinct skin, neurological, and neoplastic findings.

Purpose of the Study:

  • To summarize the key clinical features of NF1 and TSC.
  • To outline the necessary management strategies for phakomatoses.
  • To highlight the importance of surveillance for associated cancers.

Main Methods:

  • Review of characteristic clinical findings in NF1 and TSC.
  • Description of common tumor types associated with NF1 and TSC.
  • Summary of current management principles for these disorders.
Keywords:
GenodermatosesNeurocutaneous syndromesNeurofibromatosisPhakomatosesTuberous sclerosis

Related Experiment Videos

Main Results:

  • NF1 is characterized by café-au-lait macules, freckling, Lisch nodules, and tumors like neurofibromas and gliomas.
  • TSC presents with hypopigmented macules, angiofibromas, and tumors such as cortical tubers and renal/cardiac/pulmonary hamartomas.
  • Management involves supportive care, tumor monitoring, and cancer surveillance.

Conclusions:

  • Phakomatoses require comprehensive, individualized management plans.
  • Early detection and monitoring of tumors and associated cancers are crucial.
  • Multidisciplinary care is essential for optimizing patient outcomes.